EmdexTrade PLC
29 July 2004
EMDEXTRADE PLC
INTERIM REPORT
2004
EMDEXTRADE PLC
UNAUDITED INTERIM RESULTS
FOR THE SIX MONTHS TO 30 APRIL 2004
The six months to 30 April 2004 saw the benefits of cost reduction feed through
and the loss for the period fell by 74% to £129,236 compared with the same
period last year. Your Board determined to exploit opportunities to enhance
shareholder value and the Company expects to make a suitable acquisition in the
short term.
Ian Salter
Chairman
29 July 2004
EMDEXTRADE PLC
PROFIT AND LOSS ACCOUNT
FOR THE SIX MONTHS TO 30 APRIL 2004
Twelve months
Half year to Half year to to 31 October
30 April 2004 30 April 2003 2003
(Unaudited) (Unaudited) (Audited)
£ £ £
Turnover 537,679 1,047,947 1,679,238
Cost of sales (454,949) (856,099) (1,308,778)
Gross profit 82,730 191,848 370,460
Administrative expenses (211,998) (685,674) (747,072)
Operating loss (129,268) (493,826) (376,612)
Loss on sale of - - (9,162)
subsidiaries
Loss on ordinary activities before (129,268) (493,826) (385,774)
interest
Interest receivable and similar 32 110 165
income
Interest payable and similar charges - - (6,358)
Loss on ordinary activities before taxation (129,236) (493,716) (391,967)
Tax on loss on ordinary activities - (299) (63)
Loss on ordinary activities after (129,236) (494,015) (392,030)
taxation
Earnings per share
Basic earnings per share (0.29)p (1.23)p (0.97)p
Turnover is derived wholly from continuing
activities
Notes:
1. The financial statements have been prepared in accordance with applicable UK
accounting standards and under the historical cost convention. The principal
accounting policies of the company are set out in the company's 2003 annual
report.
2. The financial information set out above does not constitute statutory
accounts as defined in section 240 of the Companies Act 1985. Statutory
accounts for the twelve months to 31 October 2003, on which the report of
the auditors was qualified due to limitation of audit scope, have been
filed with the Registrar Of Companies.
3. Basic earnings per share have been calculated on the basis of the number
of shares in issue of 44,444,444, which has remained unchanged during the
period.
4. The directors are not declaring a dividend for the period.
5. Copies of this report are being sent to all shareholders and can be
viewed on the company's web-site 'www.emdextrade.com'
Business Address and Registered Office
EmdexTrade PLC
15 The Green
Richmond
Surrey
TW9 1PX
United Kingdom
Telephone +44 (0) 208 334 0871
Facsimile +44 (0) 208 334 0870
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.